To evaluate the effects of short-term treatment with calcitriol on bio
chemical markers of calcium and bone metabolism, 36 normal male volunt
eers (aged 21-54 years) were randomized to oral treatment for 7 days w
ith either (A) calcitriol, 1 mu g twice daily, (B) calcitrol, 0.5 mu g
twice daily, or (C) placebo twice daily, Serum calcium increased slig
htly in a dose-dependent manner (maximal increase 2.5%, p < 0.05) foll
owed by a heavy increase in both 24 h (max, 156.1%, p < 0.001) and fas
ting urinary calcium excretion (max, 123.1%, p < 0.001), and a strikin
g reduction in serum PTH (max, -43.1%, p < 0.001). Biochemical markers
of osteoblast activity and bone formation increased immediately in a
dose-dependent manner [serum osteocalcin (max, 37.8%, p < 0.03) and se
rum procollagen type I C-terminal propeptide (PICP) (max, 26.0%, p < 0
.05)], whereas there was no effect on serum bone alkaline phosphatase,
Calcitriol treatment had no effect on biochemical markers of bone res
orption [serum C-terminal telopeptide of type I collagen (ICTP) and fa
sting urinary excretion of hydroxyproline/creatinine (OHP)]. Extraosse
ous collagen matrix synthesis was not affected evaluated by serum proc
ollagen type III N-terminal propeptide (PIIINP). In the follow-up peri
od (15 weeks) no unequivocal changes were observed, The fast and protr
acted increase in biochemical markers of osteoblast activity and bone
formation, without affecting bone resorption and extraosseous connecti
ve tissue metabolism points toward a selective effect of calcitriol on
bone matrix formation.